share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

辉瑞 | 4：持股变动声明-董事 Quincey James
美股sec公告 ·  04/26 13:28
Moomoo AI 已提取核心信息
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
在最近的一笔交易中，辉瑞公司 [PFE] 的举报人昆西·詹姆斯于2024年4月25日执行了一笔股票交易。该交易的细节，包括所涉及的股票数量和交易价格，尚未披露。也没有提供股份的性质和昆西·詹姆斯在诉讼后持有的股票数量。这些信息对于投资者了解对辉瑞股票投资的潜在影响至关重要。
在最近的一笔交易中，辉瑞公司 [PFE] 的举报人昆西·詹姆斯于2024年4月25日执行了一笔股票交易。该交易的细节，包括所涉及的股票数量和交易价格，尚未披露。也没有提供股份的性质和昆西·詹姆斯在诉讼后持有的股票数量。这些信息对于投资者了解对辉瑞股票投资的潜在影响至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息